Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

Chart Industries (NYSE:GTLS) +17.1% post-market Monday after the Financial Times reported Baker Hughes (NASDAQ:BKR) is near a $13.6B cash deal to acquire the company, valuing Chart at $210/share, a 22 ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Chart Industries and Flowserve recently agreed to merge in an all-stock deal. The two companies outlined significant revenue and cost synergies. Strangely, both bargain-priced stocks fell after the ...

With nearly two decades of retail management and project management experience, Brett Day can simplify complex traditional and Agile project management philosophies and methodologies and can explain ...

Since 2020, Chart Industries has pivoted toward expanding its specialty portfolio of products into high-growth areas such as hydrogen and liquefied natural gas. It made several attractive investments ...